TSL.L Regulatory News (TSL)

1 Apr 2008 07:57

Nomura Code Securities Limited01 April 2008 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(b) of the Takeover Code) 1. KEY INFORMATION +-----------------------------------+-----------------------------------------+|Name of exempt principal trader |Nomura Code Securities Limited |+-----------------------------------+-----------------------------------------+|Company dealt in |Tissue Science Laboratories PLC |+-----------------------------------+-----------------------------------------+|Class of relevant security to which|10p Ordinary - ISIN GB0030978380 ||the dealings being disclosed relate| ||(Note 1) | || | |+-----------------------------------+-----------------------------------------+|Date of dealing |31-Mar-2008 || | |+-----------------------------------+-----------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in theclass of relevant securitydealt in (Note 2) +----------------------------------+---------------------+---------------------+| | Long | Short || | | |+----------------------------------+----------+----------+----------+----------+| |Number |(%) |Number ) |(%) || | | | | |+----------------------------------+----------+----------+----------+----------+|(1) Relevant securities |0 |0.0 |0 |0.0 || | | | | |+----------------------------------+----------+----------+----------+----------+|(2) Derivatives (other than |0 |0 |0 |0 ||options) | | | | || | | | | |+----------------------------------+----------+----------+----------+----------+|(3) Options and agreements to |0 |0 |0 |0 ||purchase/sell | | | | || | | | | |+----------------------------------+----------+----------+----------+----------+|Total |0 |0.0 |0 |0.0 |+----------------------------------+----------+----------+----------+----------+| | | |+----------------------------------+---------------------+---------------------+ (b) Interests and short positions in relevant securities of thecompany, other than the classdealt in (Note 2) +---------------------------------+----------------------+---------------------+|Class of relevant security: | Long | Short || | | |+---------------------------------+-----------+----------+----------+----------+| |Number |(%) |Number ) |(%) || | | | | |+---------------------------------+-----------+----------+----------+----------+|(1) Relevant securities |0 |0 |0 |0 || | | | | |+---------------------------------+-----------+----------+----------+----------+|(2) Derivatives (other than |0 |0 |0 |0 ||options) | | | | || | | | | |+---------------------------------+-----------+----------+----------+----------+|(3) Options and agreements to |0 |0 |0 |0 ||purchase/sell | | | | || | | | | |+---------------------------------+-----------+----------+----------+----------+|Total |0 |0 |0 |0 || | | | | |+---------------------------------+-----------+----------+----------+----------+ (c) Rights to subscribe (Note 2) +-----------------------------------+-----------------------------------------+|Class of relevant security: |Details || | || | |+-----------------------------------+-----------------------------------------+|n/a |n/a || | |+-----------------------------------+-----------------------------------------+ 3. DEALINGS (Note 3) (a) Purchases and sales +-----------------------------+--------------------------+--------------------+|Purchase/sale |Number of securities |Price per unit (Note|| | |4) |+-----------------------------+--------------------------+--------------------+ Purchase 31,764 103.5 pTotal Purchases: 31,764 Total Sales: Nil (b) Derivatives transactions (other than options) +----------------+-------------------+----------------------+-----------------+|Product name, |Long/short (Note 5)|Number of securities |Price per unit ||e.g. CFD | |(Note 6) |(Note 4) |+----------------+-------------------+----------------------+-----------------+|n/a |n/a |n/a |n/a || | | | |+----------------+-------------------+----------------------+-----------------+ (c) Options transactions in respect of existing securities(i) Writing, selling, purchasing or varying +------------+------------+------------+--------+---------+-------+-----------+|Product |Writing, |Number of |Exercise|Type, |Expiry |Option ||name, |selling, |securities |price |e.g. |date |money ||e.g. call |purchasing, |to which the| |American,| |paid/ ||option |varying etc.|option | |European | |received || | |relates | |etc. | |per unit || | |(Note 6) | | | |(Note 4) |+------------+------------+------------+--------+---------+-------+-----------+|n/a |n/a |n/a |n/a |n/a |n/a |n/a || | | | | | | |+------------+------------+------------+--------+---------+-------+-----------+ (ii) Exercising +-------------------------+------------------------+--------------------------+|Product name, e.g. call |Number of securities |Exercise price per unit ||option | |(Note 4) || | | |+-------------------------+------------------------+--------------------------+|n/a |n/a |n/a || | | |+-------------------------+------------------------+--------------------------+ (d) Other dealings (including new securities) (Note 3) +-------------------------+----------------------+----------------------------+|Nature of transaction |Details |Price per unit (if ||(Note 7) | |applicable) (Note 4) || | | |+-------------------------+----------------------+----------------------------+|n/a |n/a |n/a || | | |+-------------------------+----------------------+----------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +--------------------------------------------------------------------------+|Full details of any agreement, arrangement or understanding between the ||person disclosing and any other person relating to the voting rights of ||any relevant securities under any option referred to on this form or ||relating to the voting rights or future acquisition or disposal of any ||relevant securities to which any derivative referred to on this form is ||referenced. If none, this should be stated. |+--------------------------------------------------------------------------+|None || || |+--------------------------------------------------------------------------+ Is a Supplemental Form 38.5(b) attached? (Note 8) NO +---------------------------------------------+-------------------------------+|Date of disclosure |01-Apr-2008 || | |+---------------------------------------------+-------------------------------+|Contact name |Niall Campbell || | |+---------------------------------------------+-------------------------------+|Telephone number |020 7776 1226 || | |+---------------------------------------------+-------------------------------+|Name of offeree with which connected |Tissue Science Laboratories PLC|+---------------------------------------------+-------------------------------+|Nature of connection (Note 9) |Adviser & Broker || | |+---------------------------------------------+-------------------------------+ Notes The Notes on Form 38.5(b) can be viewed on the Takeover Panel's websiteat www.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange